HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary amyloidosis (AL) presenting with nephrotic syndrome: a case report and discussion.

Abstract
Primary amyloidosis (AL) is a rare disorder with only eight cases per million a year. AL is a plasma cell disorder in which neoplastic clonal plasma cells in the bone marrow produce monoclonal immunoglobulin light chains that form protease resistant amyloid fibrils. AL fibrils accumulate within tissues systemically, causing progressive organ impairment to ultimate death. Median survival in AL with treatment is only 17 months depending upon variable prognostic factors. Most patients present with nephrotic syndrome and associated peripheral edema because the kidney is the most common organ involved in AL. This article describes the case of a patient who presented to City Hospital in Martinsburg, W.Va., and was diagnosed with primary amyloidosis, and reviews the current literature on this illness.
AuthorsLisa Musolin, Roberto Reyna, Jeffrey DeBord
JournalThe West Virginia medical journal (W V Med J) Vol. 99 Issue 1 Pg. 28-30 ( 2003) ISSN: 0043-3284 [Print] United States
PMID12762214 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Amyloidosis (complications, drug therapy)
  • Edema (drug therapy, etiology)
  • Fatigue (etiology)
  • Female
  • Humans
  • Hypercholesterolemia (complications)
  • Middle Aged
  • Nephrotic Syndrome (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: